Insulet
PODD
#1018
Rank
S$25.58 B
Marketcap
$364.35
Share price
-0.49%
Change (1 day)
63.88%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.45 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.07 Billion. , an increase over its 2023 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 S$0.45 B36.72%
2023 S$0.33 B481.9%
2022 S$57.58 M-45.24%
2021 S$0.10 B43.35%
2020 S$73.34 M18.51%
2019 S$61.89 M41.16%
2018 S$43.84 M-711.95%
2017 -S$7.17 Million-56.85%
2016 -S$16.61 Million-79.31%
2015 -S$80.28 Million63.85%
2014 -S$49 Million31.04%
2013 -S$37.39 Million-21.96%
2012 -S$47.92 Million
2010 -S$45.7 Million-42.38%
2009 -S$79.31 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$71.94 Million209.75%
2006 -S$23.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$54.14 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.13 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.97 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.30 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.36 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.98 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$16.94 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA